Murakami, S., Shibaki, R., Matsumoto, Y., Yoshida, T., Goto, Y., Kanda, S., . . . Ohe, Y. (2020). Association between serum level soluble programmed cell death ligand 1 and prognosis in patients with non‐small cell lung cancer treated with anti‐PD‐1 antibody. Thorac Cancer.
Chicago-tyylinen lähdeviittausMurakami, Shuji, et al. "Association between Serum Level Soluble Programmed Cell Death Ligand 1 and Prognosis in Patients With Non‐small Cell Lung Cancer Treated With Anti‐PD‐1 Antibody." Thorac Cancer 2020.
MLA-viiteMurakami, Shuji, et al. "Association between Serum Level Soluble Programmed Cell Death Ligand 1 and Prognosis in Patients With Non‐small Cell Lung Cancer Treated With Anti‐PD‐1 Antibody." Thorac Cancer 2020.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.